Trial Details
COMPLETEDBasic Information
| Clinical ID | c1494 |
|---|---|
| Identifier | NCT02522767 |
| Trial Title | Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Mesalamine|DRUG: Placebo |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | Little Rock |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-10-15 |
|---|---|
| Primary Completion Date | 2018-02-06 |
| Completion Date | 2018-04-03 |